Metamark Laboratory Services
Metamark is a pioneer in science with a mission to provide breakthrough diagnostic and prognostic solutions for urological cancer care.
We offer a range of high-quality, comprehensive lab services out of our accredited laboratories in Cambridge, MA, and Augusta GA, backed by superior clinical expertise and the highest level of customer support.
An advanced proteomic prognostic test developed specifically for prostate cancer. Following a prostate biopsy, ProMark uses sophisticated automated image recognition technology to predict your Gleason Score 3+3 and 3+4 patient’s risk of having an aggressive prostate cancer. Make a more informed and confident decision about your patient’s individual path of treatment.
The first urine-based molecular test that delivers confidence to make informed repeat biopsy decisions. Highly specific and easy to use, Progensa PCA3 provides additional information to help improve your biopsy decisions.
Our cytology diagnostic services provide superior specificity in the diagnosis of bladder cancer.
FISH, or fluorescence in situ hybridization — a diagnostic tool that may help confirm your patient’s cytology results, monitor bladder cancer recurrence, and measure treatment response. Identify genetic changes at the chromosomal level, before cancer is visible.
Our histology diagnostic services include expert prostate and bladder biopsy analysis as well as supporting services and examinations.
PTEN/ERG molecular testing predicts the aggressiveness of your HGPIN/atypical or low Gleason Score 6 and 7 prostate cancer patients. Additional, reliable information providing greater insight to make better treatment decisions.
Questions about Metamark products, services, or billing processes? We’re here to help.
Call us at 1 (877) 743-3338, Monday through Friday, 8:00 a.m. to 5:30 p.m., EST.
Next: Progensa® PCA3